In this video:
Keynote Address by Atanu Roy, Group CIO, Biocon Group
Key Highlights:
1. Technology has shifted focus to personalised medicines or targeted therapies with a purpose to prevent and manage diseases
2. Explosion in integrated and automated insights from IoT devices, RW applications, clinical data, Social media, medical science and more
3. Increasing manufacturing complexity will shift from small molecule to biologics and the introduction of cell and gene therapies
4. Rapid digitisation of processes using RPA, low code platforms, etc